OIW — Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types Class II

FDA Device Classification

FDA product code OIW covers "Software, Similarity Score Algorithm, Tissue Of Origin For Malignant Tumor Types", a Class II medical device regulated under 21 CFR 862.3100. Submissions are reviewed by the Clinical Toxicology panel. At least 4 recent 510(k) clearances have been granted under this product code.

Classification Details

Product Code
OIW
Device Class
Class II
Regulation Number
862.3100
Submission Type
Review Panel
TX
Medical Specialty
Clinical Toxicology
Implant
No

Definition

This test is intended to measure the degree of similarity between the RNA expression pattern in a patient?s fresh-frozen tumor and the RNA expression patterns in a database of tumor samples for some common malignant tumor types that were diagnosed according to then current clinical and pathological practice. The test result is intended for use in the context of the patient?s clinical history and other diagnostic tests evaluated by a qualified clinician. The test is not intended to establish the origin of tumors (e.g. carcinoma of unknown primary) that cannot be diagnosed according to current clinical and pathological practice.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K173839cancer geneticsTissue of Origin Test Kit-FFPEMarch 15, 2018
K120489pathwork diagnosticsTISSUE OF ORIGIN TEST KIT FFPEMay 17, 2012
K092967pathwork diagnosticsPATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPEJune 8, 2010
K080896pathwork diagnosticsPATHWORK DIAGNOSTICS TISSUE OF ORIGIN TESTJuly 30, 2008